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a b s t r a c t
The inability of neurites to grow and restore neural connections is common to many neurological dis-
orders, including trauma to the central nervous system and neurodegenerative diseases. Therefore, there
is need for a robust and reproducible model of neurite outgrowth, to provide a tool to study the mo-
lecular mechanisms that underpin the process of neurite inhibition and to screen molecules that may be
able to overcome such inhibition. In this study a novel in vitro pluripotent stem cell based model of
human neuritogenesis was developed. This was achieved by incorporating additional technologies,
notably a stable synthetic inducer of neural differentiation, and the application of three-dimensional (3D)
cell culture techniques. We have evaluated the use of photostable, synthetic retinoid molecules to pro-
mote neural differentiation and found that 0.01 mM EC23 was the optimal concentration to promote
differentiation and neurite outgrowth from human pluripotent stem cells within our model. We have
also developed a methodology to enable quick and accurate quantiﬁcation of neurite outgrowth derived
from such a model. Furthermore, we have obtained signiﬁcant neurite outgrowth within a 3D culture
system enhancing the level of neuritogenesis observed and providing a more physiological microenvi-
ronment to investigate the molecular mechanisms that underpin neurite outgrowth and inhibition
within the nervous system. We have demonstrated a potential application of our model in co-culture
with glioma cells, to recapitulate aspects of the process of neurite inhibition that may also occur in
the injured spinal cord. We propose that such a system that can be utilised to investigate the molecular
mechanisms that underpin neurite inhibition mediated via glial and neuron interactions.
© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
During neuronal development, dynamic processes involving
cytoskeletal remodelling occur, known as neuritogenesis. Long
cytoskeletal processes, known as neurites, project from the cell
body of the developing neuron and ultimately form distant neural
connections that become the axon and dendrites of a mature neural
network (Da Silva and Dotti, 2002). The growth cone is situated at
the distal tip of the developing neurite and is rich in actin ﬁlaments
(Khodosevich and Monyer, 2010) and microtubules (Dent et al.,
2011), along with adaptor proteins, as it undergoes signiﬁcant
cytoskeletal rearrangements during neurite elongation. Primarily
the remodelling of the actin cytoskeleton drives protrusion and
motility of the growth cone; therefore actin dynamics play an
important role during neuritogenesis (Dent et al., 2011).
Complex neuronal networks are essential for nervous system
function, and depend on the successful formation of neurite pro-
jections from the developing neuron. Accordingly, neuritogenesis is
an integral process essential to the proper functioning of the ner-
vous system (Da Silva and Dotti, 2002). Inhibition of neurite
outgrowth is common to many nervous system disorders including
central nervous system trauma (Rolls et al., 2009; Yiu and He,
2006a; Niederost et al., 2002; Bush et al., 1999) and
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neurodegenerative diseases (Petratos et al., 2008; Postuma et al.,
2000; Takenouchi et al., 2001; Winner et al., 2011). This high-
lights the importance of in vitro models of neuritogenesis to
enhance our understanding of the process and to screen potential
therapeutic molecules.
Many of the popular current models of neurite outgrowth
include the isolation and in vitro culture of primary mammalian cell
types derived from the nervous system of rats andmice. Dorsal root
ganglia (DRG) neurons and explants derived from mammalian or
chick embryos are commonly isolated and cultured in vitrowithout
the need for differentiation and form the basis of many neurite
outgrowth studies (Clagett-Dame et al., 2006; Balgude et al., 2001;
Fitzgerald et al., 1993). Although the use of primary cells avoids the
limitations associated with immortalised cell lines, the physiology
of animal derived cells may differ signiﬁcantly from that of human
cells and impact experimental outcomes. This becomes particularly
important when applying such models to human neurological
diseases. Human cell lines such as SH-SY5Y are commonly used to
study neurite outgrowth (Ferrari-Toninelli et al., 2004; Tucholski
et al., 2001; Ross et al., 1983). SH-SY5Y cells are a popular neuro-
blastoma cell line that originated from a metastatic bone biopsy
that require differentiation with all-trans retinoic acid (ATRA)
(Kovalevich and Langford, 2013). However, due to their neoplastic
nature, mixed morphology, and somewhat limited capacity for
neuritogenesis, questions have arisen as to the consistency and
appropriateness of the use of such cells in neurite outgrowth
models, particularly when the application may be to test potential
therapeutics (Kovalevich and Langford, 2013).
Human pluripotent stem cells are recognised models of neural
development. The embryonal carcinoma (EC) stem cell line, TERA2,
readily differentiates into neuronal subtypes when exposed to
ATRA. EC cells are the malignant counterpart of embryonic stem
cells, and cells from the TERA2 lineage have provided the basis for
many in vitromodels of neural differentiation, function and neurite
outgrowth (Tegengem et al., 2011; Satoh et al., 1997; Pewsey et al.,
2010; Roloff et al., 2015; Przyborski, 2001; Przyborski et al., 2000,
2003, 2004; Stewart et al., 2004; Coyne et al., 2011). While such
models are valuable, there is signiﬁcant scope to enhance their
reliability in terms of robustness and reproducibility.
Cell technologies are becoming available which are designed to
improve current practice, and enhance the development and
application of in vitro assays. Such techniques can be used to
improve the robustness and reproducibility of neurite outgrowth
assays and enhance their physiological signiﬁcance. For example,
ATRA is a derivative of vitamin A, which is important during the
patterning and differentiation of the developing nervous system
in vivo (Magden, 2007). However, the use of ATRA in vitro is limited,
as it readily breaks down when exposed to light and heat. Stable,
synthetic forms of retinoic acid such as, EC23 and AH61 offer more
practical in vitro use, as they contain a non-isomerisable conjugated
linker unit that stabilises the molecule, and have previously been
described as tools for stem cell differentiation studies (Clemens
et al., 2013; Christie et al., 2008). In recent years there has been
growing interest in 3D culture techniques to enhance the physio-
logical relevance of in vitromodels. Many existingmodels of neurite
outgrowth use conventional two-dimensional (2D) cell culture,
rather than culturing developing neurites in a more physiological
three-dimensional (3D) system. 3D scaffolds have been developed
to enhance neurite development (Hayman et al., 2004, 2005).
Another limitation of current 2D neurite outgrowth models is that
they are difﬁcult to quantify, as monolayers of developing neurons
intertwine and form complex neuronal networks within the cell
population, making it difﬁcult to identify individual neurites
emanating from individual perikarya. We propose that quantiﬁca-
tion of neurite outgrow can be simpliﬁed using a neurosphere
model, whereby all neurites radiate from a central point aiding
quantiﬁcation and signiﬁcantly reducing neurite network
complexity.
In this study we have combined our stem cell model of human
neuritogenesis with synthetic retinoids and 3D cell culture tech-
nologies to produce an enhanced model of neurite development
and outgrowth. This provides a powerful new tool to study neurite
inhibition and to investigate the molecular processes involved in
the context of different neurological disorders. Here, we present an
example application of this system, to study the process of neurite
inhibition and the ability of small molecules to overcome such in-
hibition. Such research tools will be important to help elucidate the
mechanisms that underpin neurite inhibition to enable interven-
tion and recovery of neurite outgrowth.
2. Material & methods
2.1. Cell line maintenance
2.1.1. Human pluripotent stem cells
The EC cell line TERA2.cl.SP12, was maintained in maintenance
medium consisting of Dulbecco's modiﬁed Eagles medium con-
taining high glucose (DMEM-HG, Lonza, Basel, Switzerland), 10%
heat treated foetal bovine serum (FBS, ThermoFisher Scientiﬁc,
Cramlington, UK), 2 mM L-glutamine (Lonza) and 20 active units of
penicillin and streptomycin (Lonza). EC cells were maintained at
high conﬂuence and passaged using acid washed glass beads in a
2e3 ratio into 75 cm (Khodosevich andMonyer, 2010) culture ﬂasks
(BD Falcon, Erembodegem, Belgium) to ensure their pluripotent
phenotype. A Leica DFC 310FX with digital camera DMI 3000B was
used to record phase contrast images of live cells.
2.1.2. U-118 MG glioma cells
U-118MG cells weremaintained in DMEM-HG,10% FBS, 2 mM L-
glutamine and 100 active units of penicillin and streptomycin. Cells
were maintained in 75 cm2 culture ﬂasks (ThermoFisher Scientiﬁc)
and passaged at high conﬂuence in a 3e6 ratio using 0.25% trypsin/
2 mM EDTA (Lonza).
2.2. Induction of cell differentiation in conventional 2D culture
TERA2.cl.SP12 stem cells were seeded at 250,000 cells per 25 cm
(Khodosevich and Monyer, 2010) culture ﬂask (BD Falcon) and
incubated for 24 h to allow cells to adhere. Following 24 h incu-
bation, the culture medium was replaced with media containing
ATRA Sigma-Aldrich, EC23 (ReproCELL Europe, UK) or AH61
(Chemistry Department, Durham, UK) in dimethyl sulfoxide
(DMSO) at concentrations of 0.001 mM, 0.01 mM, or 1 mM. Cells were
cultured for a further 7 days with a media change on the 4th day
prior to analysis of cell surface markers by ﬂow cytometry or lysis
for Q-PCR.
2.3. Analysis of protein expression by ﬂow cytometry
Following the 7 day differentiation period a single cell suspen-
sion was obtained through the trypsinisation of monolayers and
cells were resuspended in blocking buffer (0.1% bovine serum al-
bumin (BSA, Sigma-Aldrich) in phosphate buffered saline (PBS)) at a
density of 0.2  106 cells per well of a 96 well plate (Greiner Bio-
one, Stonehouse, UK). The plate was centrifuged at 1000 rpm for
3 min at 4 C, and the pellet was resuspended in the appropriate
primary antibody (anti-p3X (gift from Prof. Peter Andrews, Shef-
ﬁeld University, UK), anti-SSEA3 (Developmental Studies Hybrid-
oma Bank, Iowa, USA), anti-TRA-160 (Millipore, Darmstadt,
Germany) or anti-A2B5 (R&D Systems, Abingdon, UK)) for 60 min.
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The cells were then washed 3 times in blocking buffer prior to in-
cubation with the secondary antibody (anti-mouse IgM (Sigma-
Aldrich)) for 60 min. Cells were then washed a further three times
in blocking buffer and resuspended in blocking buffer prior to
analysis using the Guava Easy Cyte Plus and Cytosoft software
(Millipore), and settings adjusted to the negative control (P3X), a
murinemarker that is not be expressed on human cells to take non-
speciﬁc staining into account.
2.4. Real time quantitative polymerase chain reaction (Q-PCR)
Q-PCR was carried out on cells immediately following lysis.
Commercial RNA extraction (Qiagen) and reverse transcription
(ThermoFisher) kits were used following manufacturer's in-
structions. Following lysis, cells were homogenised using a 20-
gauge needle and passed through an RNeasy spin column. DNase
digestion was carried out prior to RNA extraction from the column
as a suspension in RNase free water. RNA quantity was determined
using a Nanodrop Spectrophotometer ND-100™, followed by
analysis on a 1% agarose gel. Reverse transcription was carried out
using a high-capacity cDNA reverse transcription kit and a Biometra
T1 thermal cycler. The expression of genes (Nanog (ThermoFisher),
Oct-4 (ThermoFisher) and Pax6 (ThermoFisher)) was quantiﬁed
against Glyceraldehyde-3-phosphate dehydrogenase (GAPDH, Ther-
moFisher) and Q-PCR was analysed using an Applied Biosystems
RT-PCR system.
2.5. Formation of neurospheres
To form stem cell aggregates, cells were trypsinised and seeded
in a single cell suspension at a density of 1.5  106 cells per sterile,
on an untreated 90 mm Petri dish (ThermoFisher Scientiﬁc) and
incubated for 24 h prior to retinoid treatment. Following 24 h,
retinoid compounds were added directly to induce neural differ-
entiation; cultures were further maintained with retinoid com-
pounds for 21 days with media changes, replenishing retinoid
treatment, twice per week.
2.6. Induction of neurite outgrowth
Following 21 days, differentiated aggregates, were seeded into
either 48-well culture plates or 12-well format Alvetex® scaffold
inserts (ReproCELL Europe, UK). Alvetex® scaffolds were rendered
hydrophilic by plasma treatment using the K1050 Plasma Asher at
a power level of 40W, for 5 min. Treated scaffolds and conventional
culture plates were coated overnight at room temperature with
10 mgml1 poly-D-lysine (Sigma-Aldrich) and 10 mgml1 laminin
(Sigma-Aldrich) solution. Stem cell aggregates were subsequently
maintained for a further 10 days with mitotic inhibitors: 1 mM
cytosine arabinoside (Sigma-Aldrich), 10 mM 5'ﬂuoro2'deoxyur-
idine (Sigma-Aldrich) and 10 mM uridine (Sigma-Aldrich) on coated
Alvetex® or culture plates. Cells were then ﬁxed with 4% para-
formaldehyde (PFA) in PBS for 60 min and processed for immu-
noﬂuorescence and histological analysis.
2.7. Co-culture of glioma cells and neurospheres
Glioma cells (U-118 MG), were seeded at a density of
1  106 cells in a volume of 100 mL of media to the surface of a
prepared scaffold and allowed to settle for 15 min at 37 C. Neu-
rospheres were then added to the surface of the scaffold as previ-
ously described in Section 2.6 and incubated in the presence or
absence of 10 mM Y-27632 (a selective p160 ROCK inhibitor) and
mitotic inhibitors for 10 days, and subsequently ﬁxed with 4% PFA
for processing and analysis.
2.8. Immunoﬂuorescent analysis of 2D cultures and 3D models
Both 2D and 3D cultures ﬁxed with 4% PFA were permeabilised
with 0.1% Triton X-100 (Sigma-Aldrich) in PBS for 10 min and
blocked on ice for 60 min with 1% goat serum (Sigma-Aldrich) and
0.01% Tween (Sigma-Aldrich) in PBS. 2D cell culture samples were
then incubated with primary antibodies (anti-beIIIetubulin
(Cambridge bioscience, Cambridge, UK), anti-nestin (Abcam,
Cambridge, UK), anti-Neuroﬁlament-H (Abcam), anti-
neuroﬁlament-M (Sigma-Aldrich) or anti-neuroﬁlment-L (Sigma-
Aldrich)) on ice for 60 min, whereas cells on Alvetex® scaffolds
were incubated for 120 min before being washed 3 times in
blocking buffer. Samples were then incubated with the relevant
secondary antibody Goat anti-rabbit Alexa Fluor® 488 (Thermo-
Fisher Scientiﬁc) or Goat anti-mouse Alexa Fluor® 488 (Thermo-
Fisher Scientiﬁc) along with the nuclear dye Hoechst 33,342
(ThermoFisher Scientiﬁc) for a further 60 min. Samples were then
washed 3 times in blocking buffer and 2D samples were stored in
PBS until microscopy, whereas cells on Alvetex® scaffolds were
whole mounted onto microscope slides (ThermoFisher Scientiﬁc)
using Vectashield (Vecta Laboratories, California, USA) ﬂuorescence
mounting media. Samples were imaged using either the Zeiss 880
and Zeiss 510 confocal microscopes with Zen software, or the Leica
SP5 confocal microscope with Leica Application Suite software.
2.9. Parafﬁn embedding of 3D models
Fixed 3D cultures were dehydrated in 30% followed by 50%
ethanol. Samples were stained in 0.1% (w/v) crystal violet (Sigma-
Aldrich) dissolved in 70% ethanol to visualise the neurospheres and
further dehydrated through a series of ethanol baths. Samples were
then bathed in histoclear (ThermoFisher Scientiﬁc) for 15 min fol-
lowed by 50% histoclear, 50% parafﬁn wax mix (ThermoFisher Sci-
entiﬁc) for 30 min at 60 C. Samples were further incubated for
60 min with melted parafﬁn wax only at 60 C before being
embedded using plastic moulds (CellPath, Newton, UK) and
embedding cassettes (ThermoFisher Scientiﬁc) to allow for trans-
verse sectioning.
2.10. Haematoxylin and eosin staining of parafﬁn embedded
sections
Alvetex® Scaffold 3D parafﬁn embedded samples were
sectioned at 6 mmusing a LeicaMicrotome RM2125RTandmounted
onto charged superfrost microscope slides (ThermoFisher Scienti-
ﬁc). Sections were deparafﬁnised in Histoclear and rehydrated.
Slides were incubated in Mayer's haematoxylin (Sigma-Aldrich) for
5 min and rinsed in distilled water for 30 s before being incubated
with alkaline alcohol for 30 s to ensure the nuclei appear blue.
Samples were then dehydrated, before being incubated with eosin
(Sigma-Aldrich) for 1 min and then further dehydrated and incu-
bated in Histoclear for 3 min prior to mounting with DPX (Ther-
moFisher Scientiﬁc) ready for microscopy using a Leica ICC50 high
deﬁnition camera mounted onto a Leica microscope.
2.11. Immunoﬂuorescent analysis of 3D cultures
Alvetex® Scaffold 3D samples were deparafﬁnised and rehy-
drated as previously described. Antigen retrieval was achieved by
incubating samples in a 95 C water bath for 20 min with citrate
buffer anhydrous citric acid (Sigma-Aldrich, dissolved in (DI) wa-
ter). Samples were then permeabilised with 0.1% Triton X-100 in
PBS for 20 min and blocked with 1% goat serum (Sigma-Aldrich)
and 0.01% Tween in PBS for 30 min. Primary antibody (anti-be
IIIetubulin, anti-chondroitin sulphate (Abcam), or anti-brevican
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(Santa Cruz Biotechnology, Heidelberg, Germany)) was incubated
with the samples overnight at 4 C, followed by three washes in
blocking buffer. Samples were then incubated with the relevant
secondary antibody (Goat anti-rabbit Alexa Fluor® 488 or Goat anti-
mouse Alexa Fluor® 488), along with the nuclear dye Hoechst
33,342 for a further 60 min before being washed 3 times for 15 min
in blocking buffer and mounted using Vectashield ﬂuorescence
mounting media. Confocal images were obtained using the Zeiss
880 and Zeiss 510 confocal microscopes with Zen software, or the
Leica SP5 confocal microscope with Leica Application Suite
software.
2.12. Image analysis
Image J software was used to quantify neurite outgrowth,
through calibrating the scale of the software and tracing individual
neurites. A sampling method was employed to count neurites per
neurosphere when grown in 2D culture, whereby each image was
overlaid with a grid and a random number generator (random.org)
used to select 3 squares per image to quantify. Neurites from
neurospheres differentiated with ATRA and cultured in 2D, were
quantiﬁed using both the sampling method and tracing every
neurite per aggregate and the outcomes of both methods were
subsequently compared. A two-way ANOVA was used to assess the
statistical signiﬁcance of data generated. Our experiments showed
that for each parameter measured (number and density of neu-
rites), there was no signiﬁcant difference between counting all
neurites or using the sampling approach. Therefore the sampling
method was selected and applied to the remainder of the study. In
3D cultures using Alvetex® Scaffold, a sampling method was not
used and all neurites that visibly penetrated the scaffold were
counted.
2.13. Statistical analysis
GraphPad Prismwas used to assess the statistical signiﬁcance of
results and in all cases the statistical test ANOVA was conducted to
determine signiﬁcance with * ¼ p  0.05, ** ¼ p  0.01,
*** ¼ p  0.001, **** ¼ p  0.0001.
3. Results
3.1. Application of synthetic molecules to promote robust neural
differentiation of 2D monolayers of human pluripotent stem cells
Monolayers of TERA2.cl.SP12 stem cells were cultured with
retinoid compounds for 7 days to induce neuronal differentiation.
As can be seen in Fig. 1A, phase contrast micrographs show the
typical stem cell morphology of undifferentiated cells, note cells are
at high conﬂuency and packed tightly into colonies, whereas
monolayers of cells treated with 0.01 mM ATRA have areas where
cells appear larger and lose their characteristic stem cell
morphology (Fig. 1B). Similarly, monolayers treated with synthetic
retinoids EC23 and AH61 (Fig. 1C and D) loose their stem cell-like
morphology and possess a more differentiated phenotype.
Analysis of cell surface marker expression by ﬂow cytometry
indicated that the percentage of cells expressing the pluripotency
marker SSEA-3 (Fig. 1E) declines with increasing concentration of
all retinoid compounds tested. Treatment with the synthetic reti-
noids EC23 and AH61 results in signiﬁcantly less SSEA-3 expression
than treatment with ATRA at all concentrations. AH61 treatment
induced SSEA-3 loss to a signiﬁcantly greater extent than EC23 at all
concentrations. A marker of early neuronal differentiation, A2B5
(Fig. 1F) is expressed highly upon retinoid treatment. Particularly at
lower concentrations, 0.001 mM and 0.01 mM, A2B5 expression is
signiﬁcantly higher in cells treated with synthetic retinoids,
compared to ATRA, indicating greater neural induction. However,
as retinoid concentrations increase, the difference between the
compounds becomes smaller and at 1 mM there is no signiﬁcant
difference in A2B5 expression among the compounds tested.
Expression of genes associated with pluripotency was also
analysed through Q-PCR with Nanog and Oct-4 exhibiting similar
expression patterns following retinoid treatment (Fig. 1G and H).
Both transcription factors were highly expressed at lower concen-
trations of all compounds and expression was lost in a dose-
dependent manner as concentrations increased. EC23 and AH61
induced loss of expression of the transcription factors at much
lower concentrations, than ATRA treatment, suggesting an
enhanced potency of the synthetic molecules compared to natu-
rally occurring ATRA. Pax6, a transcription factor involved in neural
commitment, was expressed in a dose-dependent manner with
increasing retinoid concentration. Pax6 was expressed at much
higher levels in cells treated with the synthetic molecules, EC23
and AH61, compared with ATRA (Fig. 1I). EC23 treatment induces
maximal Pax6 expression; suggesting EC23 promotes neural
commitment and differentiation to a greater extent than the other
molecules at the same concentration, further indicating that EC23
is a more potent inducer of neural differentiation.
3.2. Development and characterisation of a robust and reproducible
pluripotent stem cell derived model of neurite outgrowth in 2D
culture
A sampling procedure was developed to establish an efﬁcient
and accurate method to measure neurite outgrowth. Stem cell
derived neurospheres, differentiated with increasing concentra-
tions of ATRA, were ﬁrst analysed by tracing every neurite per
neurosphere using image analysis software (Fig. 2A). The same data
set was then analysed again by overlaying a grid onto the image and
randomly selecting three squares per image to quantify neurite
outgrowth (Fig. 2B). Although neurite outgrowth may not be
entirely consistent around each neurosphere, the two data sets
were compared and a statistical analysis demonstrated no signiﬁ-
cant difference in the average number of neurites calculated per
neurosphere (Fig. 2C) or the density of the neurites (Fig. 2D) when
using either of the two methods of quantiﬁcation. The sampling
method was subsequently used as a satisfactory method of neurite
quantiﬁcation.
The ability of synthetic retinoids to induce neurite outgrowth
from neurospheres was analysed over a range of concentrations
(0.001 mMe10 mM). Neurite outgrowth was observed using
immunoﬂuorescence (Fig. 3A), whereby nuclei (blue, Hoechstþ)
remained within the central cell aggregate while neurites (green,
TUJ-1þ) extended radially from the central aggregate body. Cell
aggregates differentiated with ATRA (Fig. 3Aa,d) appeared to have
produced less neurites and neurite outgrowth appears to be less
uniform, than those aggregates differentiated with the same con-
centration of EC23 (Fig. 3Ab,e) or AH61 (Fig. 3Ac,f). Quantiﬁcation
revealed that at lower concentrations (0.001 mM and 0.01 mM),
neurospheres differentiated with the synthetic retinoids produced
signiﬁcantly more neurites per cell aggregate (Fig. 3B). This was
signiﬁcant when normalised to aggregate size and expressed as
neurite density (Fig. 3C) when compared to those differentiated
with ATRA. However, at higher retinoid concentrations (1 mM and
10 mM), the differences in neurite outgrowth between the com-
pounds became less pronounced, with the density of neurite
outgrowth not signiﬁcantly changing between the molecules
tested. This is likely due to the maximal capacity of neurite
outgrowth from the neurospheres being reached and increasing the
concentration of retinoid molecules did not increase neurite
K.E. Clarke et al. / Neurochemistry International xxx (2017) 1e114
Please cite this article in press as: Clarke, K.E., et al., A robust and reproducible human pluripotent stem cell derivedmodel of neurite outgrowth
in a three-dimensional culture system and its application to study neurite inhibition, Neurochemistry International (2017), http://dx.doi.org/
10.1016/j.neuint.2016.12.009
outgrowth further. The optimum condition for inducing neurito-
genesis from stem cell derived neurospheres was judged to be
0.01 mM EC23. This is because 0.01 mM EC23 induced signiﬁcantly
more neurites per neurosphere of greater density than aggregates
differentiated with any of the other molecules tested. This optimal
set of conditions was used to induce neuronal differentiation and
signiﬁcant neurite outgrowth for the remainder of this study.
To further characterise neuritogenesis by stem cell aggregates
differentiated with 0.01 mMEC23, expression of known cytoskeletal
markers were analysed over time. Nestin, a marker of neural stem
cells, was expressed early in culture (Fig. 4AeD), mainly at day 2,
whereas more intermediate markers of neurite outgrowth such as
neuroﬁlament-L (Fig. 4EeH) and neuroﬁlament-M (Fig. 4IeL) are
expressed later, during the intermediate stages (days 4e10) of the
neurite outgrowth period. Neuroﬁlament-H is a mature marker of
neurite outgrowth and in vivo is expressed postnatally.
Neuroﬁlament-H was expressed predominantly from day 10, with
greatest expression at day 20 in extended cultures (Fig. 4MeP). TUJ-
1, a pan neuronal marker highlights the extensions of neurites from
the aggregate over time (Fig. 4QeT), with neurites beginning to
extend at day 2 and increase in length over the 20 day culture
period.
3.3. Development of a novel stem cell derived neurite outgrowth
model within a 3D culture system
Using the neurosphere model of neurite outgrowth developed
herein, we then combined this system with established 3D cell
culture technology. Building on previous work we have shown
enhanced neuritogenesis on 3D Alvetex® Scaffold membranes
(Hayman et al., 2004, 2005). Alvetex® Scaffold is a highly porous
scaffold membrane speciﬁcally developed for 3D cell culture ap-
plications (Fig. 5). The internal structure of Alvetex® Scaffold is
highlighted using scanning electronmicroscopy (SEM) (Fig. 5A) and
comprises of 40 mm on average voids and 13 mm interconnecting
windows. Membranes of Alvetex® Scaffold are suspended in well
inserts and provide an appropriate substrate on which to perform
3D cell culture (Fig. 5B).
Neurospheres differentiated with 0.01 mM EC23, were cultured
on Alvetex® Scaffold coated with poly-D-lysine and laminin, for 10
days in the presence of mitotic inhibitors. A cross-section of the
Alvetex® Scaffold reveals that the neurosphere perikarya predom-
inantly remain on top of the scaffold membrane with few nuclei
(blue, Hoechstþ) penetrating into the material (approximately
5e10%). In contract, extensive neurite outgrowth (green, TUJ-1þ)
can be observed inside the scaffold membrane (Fig. 5C). The scaf-
fold provides an environment and physical 3D space for neurites to
grow and develop. A view from above shows the aggregate itself
remaining on top of the membrane (Fig. 5D). Neurites penetrated
the entire 200 mm thickness of the Alvetex® Scaffold, as visualized
on the bottom surface of the membrane (Fig. 5E). The number of
neurites can subsequently be counted as a measure of neurite
outgrowth through the 3D environment of the scaffold.
3.4. Application of novel 3D neurite outgrowth model to study
neurite inhibition through co-culture with glioma cells
Using the neurosphere model of neurite outgrowth combined
Fig. 1. Induction of stem cell differentiation by retinoic acid. Representative phase contrast images of stem cells cultured as 2D monolayers (A) and subsequently treated with ATRA
(B), EC23 (C) and AH61 (D) for 7 days. Flow cytometry (E) analysis of cellular expression of the stem cell marker, SSEA-3 (E) and the early neuronal marker, A2B5 (F) from 2D
monolayers treated with retinoid compounds for 7 days (data represent mean ± SEM, n ¼ 3). * ¼ p < 0.05, ** ¼ p < 0.01, *** ¼ p < 0.001, **** ¼ p < 0.0001. Analysis of gene
expression of transcription factors; Nanog (G), Oct4 (H) and PAX6 (I) measured by Q-PCR. Expression is relative to the untreated control (data represent mean ± SD, n ¼ 3). Scale
bars: 200 mm.
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with 3D Alvetex® Scaffold technology, we demonstrated the
application of this system to study inhibition of neurite outgrowth.
It is well known that neurite outgrowth is suppressed by inhibitory
mechanisms in the glial scar after injury to the spinal cord (Chen
et al., 2000; Prinja et al., 2000; Silver and Miller, 2004; McKeon
et al., 1991). Our novel model of 3D neurite outgrowth provides
an opportunity to co-culture and study growing neurites interact-
ingwith glial derivatives as amethod to investigate these inhibitory
processes.
To simulate some of the interactions between cell types
involved in the glial scar that arise post-spinal cord injury, we co-
cultured neurospheres with the astroglioma cell line, U-118 MG.
This wasmade possible due to the 3D nature of Alvetex® Scaffold, as
both cell types could be brought together within a 3D environment.
To establish the 3D culture of U-118 MG cells, cells were cultured
with mitotic inhibitors for 10 days in the scaffold membrane
(Fig. 6A). In 3D culture, the glioma cells positively expressed
chondroitin sulphate proteoglycans (CSPGs), as revealed by anti-
CSPG staining (Fig. 6B), and more speciﬁcally the CSPG brevican
(Fig. 6C). These molecules are known to inhibit neurite outgrowth
and are thought to play a major role in supressing neural regen-
eration in the damaged spinal cord (Clemens et al., 2013).
In the absence of glioma cells, neurospheres can be observed on
top of the scaffold (Fig. 6D,a; control) with extensive neurite
outgrowth penetrating the depth of the scaffold (Fig. 6D,b).
Extensive neurite outgrowth can be observed within the scaffold
through both TUJ-1 positive extensions (Fig. 6D,c) and cytoplasmic
extensions observed through haematoxylin and eosin staining
(Fig. 6D,d). The nuclei of the glioma cells (blue, Hoechstþ) can be
observed throughout the scaffold (Fig 6D,e-g). In the presence of U-
118 MG cells, few neurites radiated from the neurosphere but
instead grew over the surface of the cell aggregate (Fig. 6D,e) and
there was no evidence of any neurites having penetrated the
scaffold (Fig. 6D,f-h). The addition of the ROCK inhibitor, Y-27632,
to the co-culture system promoted neurite outgrowth, overcoming
glioma cell mediated neurite inhibition. A view from the bottom of
the scaffold allowed visualisation of neurites penetrating the scaf-
fold, even in the presence of the glioma cells (Fig. 6E). Quantiﬁca-
tion of the numbers of neurites observed on the bottom of the
membrane showed that treatment by Y-27632 overcame neurite
inhibition and enabled the recovery of neurite outgrowth to the
same levels as observed in the control condition (Fig. 6F). As sig-
niﬁcant neurite outgrowth is observed in the presence of glioma
cells and ROCK inhibition, it suggests that the inhibition of neurite
outgrowth observed is not due to physical blockage of neurite
growth by the glioma cells in the Alvetex® scaffold, but rather is due
to overcoming inhibitory factors expressed by them.
4. Discussion
Neuritogenesis is an essential process that enables the forma-
tion of complex neuronal signalling pathways. The inability of
neurons to undergo neurite outgrowth is common tomany nervous
system disorders. Impaired neurite outgrowth has been implicated
in pathologies including central nervous system trauma (Chen
et al., 2000; Prinja et al., 2000; Silver and Miller, 2004; McKeon
et al., 1991), Down's Syndrome (Bahn et al., 2002; Murtomaki
et al., 1992), schizophrenia (Ozwki et al., 2003) and neurodegen-
erative diseases such as Alzheimer's (Petratos et al., 2008; Postuma
et al., 2000) and Parkinson's Disease (Takenouchi et al., 2001). As
neurite inhibition may be common to such a large variety of
neurological disorders, it highlights the need for a well charac-
terised and physiologically representativemodel of the process that
can screen the ability of small molecules to recover such inhibition
and provide potential therapeutic strategies.
Current neurite outgrowth models routinely used within
Fig. 2. Development of an efﬁcient method for the quantiﬁcation of neurite outgrowth. Representative images showing TUJ-1 positive neurites (green) from neurospheres have
been traced using image J software (white). All neurites from each neurosphere were counted (A) and compared with a sampling method (B) (see text for further details). Scale bars:
500 mm. Quantiﬁcation of the number of neurites per neurosphere (C) and neurite density (D) for neurospheres differentiated with a range of concentrations of ATRA (0.001 mM-
10 mM), and quantiﬁed using sampling method (data represent mean ± SEM, n ¼ 2e8). No signiﬁcant (ns) difference was found between counting all neurites (fully counted) and
the more efﬁcient sampling method developed. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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neuroscience research generally utilise the differentiation of cell
monolayer cultures, whether it be of stem cells (Tegengem et al.,
2011; Satoh et al., 1997; Pewsey et al., 2010; Roloff et al., 2015),
cancer cells (Ferrari-Toninelli et al., 2004; Tucholski et al., 2001;
Ross et al., 1983) or primary animal derived cells (Clagett-Dame
et al., 2006; Balgude et al., 2001; Fitzgerald et al., 1993). However,
quantiﬁcation of neurite outgrowth in populations of cells grown as
monolayers can be challenging using image analysis software, as it
can be difﬁcult to individually trace each neurite back to its parent
cell body within an intricate neurite network (Radio and Mundy,
2008). The methodology described in this study utilises a
spheroid culture technique that promotes human neurite
outgrowth radially from a single central cell aggregate. We show
that neurites can be easily traced, using an efﬁcient sampling
method to enhance quantiﬁcation. This is more amenable to scaling
up and can more easily be adapted for high throughput screening.
The use of synthetic retinoids to differentiate pluripotent stem
cells has been evaluated within this study. ATRA is a naturally
occurring metabolite of vitamin A is often used to promote
neuronal differentiation in vitro (Bain et al., 1996; Jones-Villeneuve
et al., 1982, 1983; Andrews, 1984). However ATRA is unstable, and
breaks down when exposed to light and heat which is why its use
in vitro is limited and can give rise to inconsistency and variation
(Gurwitz and Cunnigham, 1988). We have shown the ability of
synthetic, stable retinoids to induce neural differentiation is
signiﬁcantly enhanced compared with ATRA (Clemens et al., 2013;
Christie et al., 2008). Synthetic retinoid EC23 was found to be a
potent inducer of neurite outgrowth to a much greater extent than
the other molecules tested. This was noted especially at lower
concentrations where EC23 had a greater effect than ATRA on the
Fig. 3. Induction of neural differentiation using natural and synthetic retinoids. Representative confocal images of neurospheres (A) differentiated with 0.01 mM ATRA (a,d), EC23
(b,e) and AH61 (c,f) and subsequently cultured in 2D. TUJ-1 positive neurites are highlighted in green, and nuclei in blue. Scale bars: 200 mm. High magniﬁcation image of neurites
from a typical neurosphere differentiated with 0.01 mM EC23 (e’). Scale bar: 100 mm. Quantiﬁcation examining the number of neurites per neurosphere (B) (data represent
mean ± SEM, n ¼ 15e24), and the number of neurites per mm of aggregate circumference, neurite density (C) (data represent mean ± SEM, n ¼ 15e24). * ¼ p < 0.05, ** ¼ p < 0.01,
*** ¼ p < 0.001, **** ¼ p < 0.0001. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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reduction of stem cell markers and increase in neuronal markers.
This is most likely due to its increased stability and potency as
unlike ATRA, EC23 contains a non-isomerisable conjugated linker
unit and does not readily photoisomerise (Clemens et al., 2013;
Christie et al., 2008).
In vitro models of neurite outgrowth generally utilise conven-
tional 2D cell culture methods. However, this has limitations, as the
growth of cells in 2D culture is far removed from the complex
environment that cells experience in vivo (Knight and Przyborski,
2015). Cells cultured on 2D substrates ﬂatten and remodel their
cytoskeleton resulting in changes that do not resemble the function
of their in vivo counterparts (Knight and Przyborski, 2015). Previ-
ously 3D cell culture technology has been found to enhance neu-
ritogenesis in a stem cell derived model (Hayman et al., 2004,
2005). In this study we have combined the consistency of syn-
thetic retinoids with a robust method of producing neurospheres
and quantiﬁed neurite outgrowth in 2D and 3D culture. Culturing
neurospheres in a 3D environment results in neurites growing in a
more physiological geometry without the limitations of 2D culture.
This is particularly important when screening the ability of small
molecules to promote neurite outgrowth and overcome neurite
inhibition, as a more physiologically relevant model could improve
the accuracy of predictions as to whether molecules may be suit-
able as potential therapeutics (Knight and Przyborski, 2015).
In addition, the model described in this study has the advantage
of being derived from human cells, and is more relevant for the
study of human diseases. Characterisation of this model and
assessment of markers associated with neural differentiation is
consistent with previously published evidence (Przyborski, 2001;
Przyborski et al., 2000, 2003, 2004; Stewart et al., 2004; Coyne
et al., 2011), suggesting that the neurite outgrowth observed
shares similarities with the early stages of nervous system
development.
We have described a potential application of this technology to
support investigation into the molecular mechanisms that under-
pin neurite inhibition within the injured spinal cord. An inhibitory
Fig. 4. Characterisation of neuronal differentiation through the stages of neurite outgrowth from neurospheres over 20 days in 2D culture. Expression over time of nestin (AeD),
neuroﬁlament-L (EeH), neuroﬁlament-M (IeL), neuroﬁlament-H (MeP), and TUJ-1 (QeT). Scale bars: (AeP): 50 mm, (QeT): 100 mm.
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environment arises post-spinal cord injury, known as the glial scar.
One important component of the glial scar are reactive astrocytes
that upon injury become reactive and secrete CSPG inhibitory
molecules (Fawcett and Asher, 1999; Yiu and He, 2006b;
Seidenbecher et al., 2002; Dou and Levine, 1994; Xu et al., 2015).
Immunoﬂuorescence of U-118 MG cultured within the 3D scaffold
highlights expression of such CSPG molecules, with speciﬁc stain-
ing for the molecule brevican, a member of the lectican family (Yiu
and He, 2006b), indicating that the glioma cell line expresses CSPGs
when cultured within the 3D environment.
Neurospheres derived using the methods described hereinwere
co-cultured with U-118 MG glioma cells in a 3D culture environ-
ment in an attempt to simulate aspects of the cellular interactions
between neurites and astrocytes of the glial scar. In the presence of
the U-118 MG cells, neurite outgrowth was completely lost. As
there is evidence that U-118 MG cells express CSPGs, this may
explain the inhibition of neurite outgrowth observed. We propose
that ourmodel provides a novel 3D system to study the interactions
between neuronal and glial populations and also to investigate
molecular mechanisms such as suppression of neurite growth by
chemical inhibition such as CSPGs. Small molecules can then be
applied to the system to investigate their ability to overcome such
inhibition, an example of such a molecule is Y-27632 the ROCK
inhibitor that has previously been established to overcome CSPG
mediated inhibition (Lingor et al., 2007). Here we demonstrate the
ability of Y-27632 to overcome CSPG mediated neurite inhibition
within the context of our 3D co-culture model, whereby glioma
cells are in contact with developing neurites. The ability of com-
pounds to overcome such inhibition is important in the develop-
ment of potential therapeutic strategies and the discovery of new
pharmaceuticals.
In conclusion the present study describes the optimisation of a
Fig. 5. Development of a novel 3D model of neurite outgrowth. Scanning electron micrograph demonstrating the internal structure of the scaffold membrane (A) with voids of
40 mm and interconnecting windows of 13 mm. Photograph of Alvetex® Scaffold 12-well inserts (B). Extensive neurite outgrowth can be observed within the 3D scaffold (C) with TUJ-
1þ positive neurites staining green and nuclei blue, imaged using confocal microscopy. The majority of the neurosphere remains on top of the scaffold membrane (D) with neurites
growing into the 3D material. Neurites can be visualized on the bottom of the scaffold (E), having grown through the 200 mm thick Alvetex® Scaffold membrane. Scale bars: 100 mm.
(For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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robust, reproducible and novel 3D model of neurite outgrowth that
can be quantiﬁed easily and accurately to assay neurite outgrowth.
There are many potential applications for such a model of neu-
ritogenesis including, screening potential therapeutics, studying
the developmental process of neuritogenesis or investigating the
molecular mechanisms that underpin neurite inhibition within
many neurological disorders. The systems we have developed
herein also utilise efﬁcient methods to measure and quantify
neurites in 2D and 3D culture. This is essential for the use of such a
model as a screening tool to select potential molecules that may be
able to overcome neurite inhibition for therapeutic use.
Acknowledgements
Three of the authors were supported by BBSCR CASE training
studentships. (KC; BB/K011413/1, DT; BB/G017700/1 and AH; BB/
E52798X/1)
References
Andrews, P., 1984. Retinoic acid induced neuronal differentiation of a clonal
embryonal carcinoma cell line in vitro. Dev. Biol. 103 (2), 285e293.
Bahn, S., Mimmack, M., Ryan, M., Caldwell, M., Jauniaux, E., Starkey, M.,
Svendsen, C., Emson, P., 2002. Neuronal target genes of the neuron-restrictive
silencer factor in neurospheres derived from foetuses with Down's syndrome:
a gene expression study. Lancet 359 (9303), 310e315.
Bain, G., Ray, W., Yao, M., Gottlieb, D., 1996. Retinoic acid promotes neural and re-
presses mesodermal gene expression in mouse embryonic stem cells in culture.
Biochem. Biophysical Res. Commun. 223 (3), 691e694.
Balgude, A., Yu, X., Bellamkonda, R., 2001. Agarose gel stiffness determines rate of
DRG neurite extension in 3D cultures. Biomaterials 22, 1077e1084.
Bush, T., Puvanachandra, N., Horner, C., Polito, A., Ostenfeld, Thor, Svendsen, Clive,
Mucke, Lennart, Johnson, Martin, Sofroniew, Michael, 1999. Leukocyte
Fig. 6. Development of a novel 3D co-culture model to study the interactions between neurons and glial cells. Representative heamatoxylin and eosin staining of U118MG cells
cultured alone within a 3D scaffold (A) (scale bar: 100 mm), along with CSPG (B) and brevican (C) immunostaining (scale bars: 50 mm). In the absence of co-cultured glioma cells,
neurites sprout from the neurospheres and growth can be observed through the scaffold and visualized from the bottom of the membrane (D a-c). During co-culture, the glioma
cells inhibit neurite outgrowth. Neurites grow over the surface of the neurosphere (D e) and do not penetrate the scaffold in the presence of the glioma cells (D f-h). Cross-sections
of both control and co-cultured neurospheres were stained both with the neuronal marker TUJ-1þ (D c,g) and with haematoxylin and eosin staining (D d,h). Glioma cell induced
neurite inhibition can be suppressed by application of the ROCK inhibitor, Y-27632 and signiﬁcant numbers of neurites penetrate the scaffold as visualized from the bottom of the
scaffold (E). Quantiﬁcation of neurite outgrowth from neurospheres cultured with and without glioma cells and with the addition of Y-27632 (F) (data represent mean ± SEM,
n ¼ 3). Scale bars: (D a,b,e,f, E): 250 mm, (D c,g,d,h): 100 mm.
K.E. Clarke et al. / Neurochemistry International xxx (2017) 1e1110
Please cite this article in press as: Clarke, K.E., et al., A robust and reproducible human pluripotent stem cell derivedmodel of neurite outgrowth
in a three-dimensional culture system and its application to study neurite inhibition, Neurochemistry International (2017), http://dx.doi.org/
10.1016/j.neuint.2016.12.009
inﬁltration, neuronal degeneration and neurite outgrowth after ablation of scar
forming reactive astrocytes in adult transgenic mice. Neuron 23 (2), 297e308.
Chen, M., Huber, A., can der Haar, M., Frank, M., Schnell, L., Spillmann, A., Christ, F.,
Schwab, M., 2000. Nogo-A is a myelin-associated neurite outgrowth inhibitor
and an antigen for monoclonal antibody IN-1. Nature 403, 434e439.
Christie, V., Barnard, J., Batsanov, A., Bridgens, C., Cartmell, E., Collings, J.,
Maltman, D., Redfern, C., Marder, T., Przyborski, S., Whiting, A., 2008. Synthesis
and evaluation of synthetic retinoid derivatives as inducers of stem cell dif-
ferentiation. Org. Biomol. Chem. 6 (19), 3497e3507.
Clagett-Dame, M., McNeill, E., Muley, P., 2006. Role of all-trans retinoic acid in
neurite outgrowth and extension. J. Neurobiol. 66 (7), 739e756.
Clemens, G., Flower, K., Gardner, P., Henderson, A., Knowles, J., Marder, T.,
Whiting, A., Przyborski, S., 2013. Design and biological evaluation of synthetic
retinoids: probing length vs. stability vs. activity. Mol. Biosyst. 9 (12),
3124e3134.
Coyne, L., Shan, M., Przyborski, S., Hirakawa, R., Halliwell, R., 2011. Neuropharma-
cological properties of neurons derived from human stem cells. Neurochem. Int.
59 (3), 404e412.
Da Silva, J.S., Dotti, C., 2002. Breaking the neuronal sphere: regulation of the actin
cytoskeleton in neuritogenesis. Nat. Rev. Neurosci. 3, 694e704.
Dent, E., Gupton, S., Gertler, F., 2011. The growth cone cytoskeleton in axon
outgrowth and guidance. Cold Spring Harb. Perspect. Biol. 1, 3.
Dou, C.L., Levine, J., 1994. Inhibition of neurite growth by the NG2 chondroitin
sulfate proteoglycan. J. Neurosci. 14 (12), 7516e7628.
Fawcett, J., Asher, R., 1999. The glial scar and central nervous system repair. Brain
Res. Bull. 49 (6), 377e391.
Ferrari-Toninelli, G., Paccioretti, S., Francisconi, S., Uberti, D., Memo, M., 2004.
TorsinA negatively controls neurite outgrowth of SH-SY5Y human neuronal cell
line. Brain Res. 1012, 75e81.
Fitzgerald, M., Kwiat, G., Middleton, J., Pini, A., 1993. Ventral spinal cord inhibition of
neurite outgrowth from embryonic rat dorsal root ganglia. Development 117,
1377e1384.
Gurwitz, D., Cunnigham, D., 1988. Thrombin modulates and reverses neuroblastoma
neurite outgrowth. Proc. Natl. Acad. Sci. U. S. A. 85 (10), 3440e3444.
Hayman, M., Smith, K., Cameron, N., Przyborski, S., 2004. Enhanced neurite
outgrowth by human neurons grown on solid three-dimensional scaffolds.
Biochem. Biophysical Res. Commun. 314 (2), 483e488.
Hayman, M., Smith, K., Cameron, N., Przyborski, S., 2005. Growth of human stem
cell-derived neurons on solid three-dimensional polymers. J. Biochem. Bio-
physical Methods 62 (3), 231e340.
Jones-Villeneuve, E., McBurney, M., Rogers, K., Kalnins, V., 1982. Retinoic acid in-
duces embryonal carcinoma cells to differentiate into neurons and glial cells.
J. Cell Biol. 94 (2), 235e262.
Jones-Villeneuve, E., Rudnicki, M., Harris, J., McBurney, M., 1983. Retinoic acid-
induced neural differentiation of embryonal carcinoma cells. Mol. Cell Biol. 3
(12), 2271e2279.
Khodosevich, K., Monyer, H., 2010. Signalling involved in neurite outgrowth of
postnatally born subventricular zone neurons in vitro. BMC Neurosci. 11, 18.
Knight, E., Przyborski, S., 2015. Advances in 3D cell culture technologies enabling
tissue-like structures to be created in vitro. J. Anat. 227 (6), 746e756.
Kovalevich, J., Langford, D., 2013. Considerations for the use of SH-SY5Y neuro-
blastoma cells in neurobiology. Neuronal Cell Cult. Methods Protoc. 9e21.
Lingor, P., Teusch, N., Schwarz, K., Mueller, R., Mack, H., Bahr, M., Mueller, B., 2007.
Inhibition of Rho kinase (ROCK) increases neurite outgrowth on chondroitin
sulphate proteoglycan in vitro and axonal regeneration in the adult optic nerve
in vivo. J. Neurochem. 103, 181e189.
Magden, M., 2007. Retinoic acid in the development, regeneration and maintenance
of the nervous system. Nat. Rev. Neurosci. 8 (10), 755e765.
McKeon, R., Schreiber, R., Rudge, J., Silver, J., 1991. Reduction of neurite outgrowth in
a model of glial scarring following CNS injury is correlated with the expression
of inhibitory molecules on reactive astrocytes. J. Neurosci. 11 (11), 3398e3411.
Murtomaki, S., Risteli, J., Risteli, L., Kolvisto, U., Johannson, S., Liesi, P., 1992. Laminin
and its neurite outgrowth-promoting domain in the brain of Alzheimer's Dis-
ease and Down's syndrome patients. J. Neurosci. Res. 32, 261e273.
Niederost, B., Oertle, T., Fritsche, J., McKinney, A., Bandtlow, C., 2002. Nogo-A and
myelin associated glycoprotein mediate neurite growth inhibition by antago-
nistic regulation of RhoA and Rac1. J. Neurosci. 22 (23), 10368e10376.
Ozwki, Y., Tomoda, T., Kleiderlein, J., Kamiya, A., Bord, L., Fujii, K., Okawa, M.,
Yamada, N., Hatten, M., Snyder, S., Ross, C., Sawa, A., 2003. Disrupted-in-
Schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-line
(NUDEL) and inhibits neurite outgrowth. Proc. Natl. Acad. Sci. U. S. A. 100 (1),
289e294.
Petratos, S., Li, Q.X., George, A., Kerr, M., Unabie, S., Hatzinisirou, I., Maksel, D.,
Aguilar, M.I., Small, D., 2008. The b-amyloid protein of Alzheimer's disease in-
creases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism. Brain 131,
90e108.
Pewsey, E., Bruce, C., Tonge, P., Evans, C., Ow, S., Georglou, S., Wright, P., Andrews, P.,
Fazeli, A., 2010. Nuclear proteome dynamics in differentiating embryonic car-
cinoma (NTERA-2) cells. J. Proteome Res. 9 (7), 3412e3426.
Postuma, R., He, W., Nunan, J., Beyreuther, K., Masters, C., Barrow, C., Small, D., 2000.
Substrate bound b-amyloid peptides inhibit cell adhesion and neurite
outgrowth in primary neuronal cultures. J. Neurochem. 74 (3), 1122e1130.
Prinja, R., Moore, S., Vinson, M., Blake, S., Morrow, R., Christie, G., Michalovich, D.,
Simmons, D., Walsh, F., 2000. Neurobiology: inhibitor of neurite outgrowth in
humans. Nature 403, 383e384.
Przyborski, S.A., 2001. Isolation of human embryonal carcinoma stem cells by
immunomagnetic sorting. Stem Cells 19, 500e504.
Przyborski, S.A., Morton, I.E., Wood, A., Andrews, P.W., 2000. Developmental
regulation of neurogenesis in the pluripotent human embryonal carcinoma cell
line NTERA-2. Eur. J. Neurosci. 12, 3521e3528.
Przyborski, S., Smith, S., Wood, A., 2003. Transcriptional proﬁling of neuronal dif-
ferentiation by human embryonal carcinoma stem cells in vitro. Stem Cells 21
(4), 459e471.
Przyborski, S.A., Christie, V.B., Hayman, M.W., Stewart, R., Horrocks, G.M., 2004.
Human embryonal carcinoma stem cells: models of embryonic development in
humans. Stem Cells Dev. 13, 400e408.
Radio, N., Mundy, W., 2008. Developmental neurotoxicity testing in vitro: models
for assessing chemical effects on neurite outgrowth. NeuroToxicicology 29 (3),
361e376.
Rolls, A., Shechter, R., Schwartz, M., 2009. The bright side of the glial scar in CNS
repair. Nat. Rev. Neurosci. 10, 235e241.
Roloff, F., Scheiblich, H., Dewitz, C., Dempewolf, S., Stern, M., Bicker, G., 2015.
Enhanced neurite outgrowth of human model (NT2) neurons by small-
molecule inhibitors of Rho/ROCK signaling. PLoS One 10 (2), e0118536.
Ross, R., Spengler, B., Biedler, J., 1983. Coordinate morphological and biochemical
interconversion of human neuroblastoma cells. J. Natl. Cancer Inst. 71 (4),
741e747.
Satoh, J., Yukitake, M., Kurohara, K., Kuroda, Y., 1997. Retinoic acid-induced neuronal
differentiation regulates expression of mRNAs for neurotrophins and neuro-
trophin receptors in a human embryonal carcinoma cell line NTera2. Neuro-
pathology 17 (2), 80e88.
Seidenbecher, C., Smalla, K.H., Fischer, N., Gundelﬁnger, E., Kreutz, M., 2002. Bre-
vican isoforms associate with neural membranes. J. Neurochem. 83, 728e746.
Silver, J., Miller, J., 2004. Regeneration beyond the glial scar. Nat. Rev. Neurosci. 5,
146e156.
Stewart, R., Coyne, L., Lako, M., Halliwell, R.F., Przyborski, S.A., 2004. Human
embryonal carcinoma stem cells expressing green ﬂuorescent protein form
functioning neurons in vitro: a research tool for co-culture studies. Stem Cells
Dev. 13, 646e657.
Takenouchi, T., Hashimoto, M., Hsu, L., Machowski, B., Rochenstein, E., Mallory, M.,
Masliah, E., 2001. Reduced neuritic outgrowth and cell adhesion in neuronal
cells transfected with human a-synuclein. Mol. Cell. Neurosci. 17 (1), 141e150.
Tegengem, M., Roloff, F., Bicker, G., 2011. Rapid differentiation of human embryonal
carcinoma stem cells (NT2) into neurons for neurite outgrowth analysis. Cell.
Mol. Neurobiol. 31 (4), 635e643.
Tucholski, J., Lesort, M., Johnson, G., 2001. Tissue transglutaminase is essential for
neurite outgrowth in human neuroblastoma SH-SY5Y cells. Neuroscience 102
(2), 481e491.
Winner, B., Melrose, H., Zhao, C., Hinkle, K., Yue, M., Kent, C., Braithwaite, A.,
Ogholikhan, S., Aigner, R., Winkler, J., Farrer, M., Gage, F., 2011. Adult neuro-
genesis and neurite outgrowth are impaired in LRRK2 G2019S mice. Neurobiol.
Dis. 41 (3), 706e716.
Xu, B., Park, D., Ohtake, Y., Li, H., Hayat, U., Liu, J., Selzer, M., Longo, D., Li, S., 2015.
Role of CSPG receptor LAR phosphatase in restricting axon regeneration after
CNS injury. Neurobiol. Dis. 73, 36e48.
Yiu, G., He, Z., 2006. Glial inhibition of CNS axon regeneration. Nat. Rev. Neurosci. 7,
617e627.
Yiu, G., He, Z., 2006. Glial inhibition of CNS axon regeneration. Nat. Rev. Neurosci. 7,
617e662.
K.E. Clarke et al. / Neurochemistry International xxx (2017) 1e11 11
Please cite this article in press as: Clarke, K.E., et al., A robust and reproducible human pluripotent stem cell derivedmodel of neurite outgrowth
in a three-dimensional culture system and its application to study neurite inhibition, Neurochemistry International (2017), http://dx.doi.org/
10.1016/j.neuint.2016.12.009
